· Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily...

29

Transcript of  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily...

Page 1:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 2:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 3:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 4:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 5:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 6:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 7:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 8:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 9:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 10:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 11:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 12:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 13:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 14:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 15:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 16:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 17:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 18:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 19:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 20:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 21:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 22:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 23:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 24:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 25:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 26:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 27:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 28:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based
Page 29:  · Presentation Molecular pathway Survival Left: ... cream with moisturizer. and twice daily TopiCaI Alclometasone 0.05% Cream Fluocinonide cream bid Clindamycin . Evidence—based